Upper extremity deep vein thrombosis: A community-based perspective
Am J Med. 2007 Aug;120(8):678-84
¾å»è¤Ë¤â¿¼ÉôÀÅÌ®·ìÀò¾É¤Ã¤ÆÈ¯¾É¤¹¤ë¤ó¤Ç¤¹¤Í¡¢ÃѤº¤«¤·¤Ê¤¬¤éÃΤê¤Þ¤»¤ó¤Ç¤·¤¿¡£Pub Med¤Ç¸¡º÷¤¹¤ë¤È1000·ï°Ê¾å¥Ò¥Ã¥È¤·¤Æ¤Ó¤Ã¤¯¤ê¡£²¼»è¤Î¿¼ÉôÀÅÌ®·ìÀò¾É¤Î¤ß¤Ê¤é¤º¡¢¾å»è¤Î¿¼ÉôÀÅÌ®·ìÀò¾É¤â¤³¤Î10ǯ´Ö¤ÇµÞÁý¤·¤Æ¤¤¤ë¤½¤¦¤Ê¤Î¤Ç¤¹¤¬¡¢¥ê¥¹¥¯¥Õ¥¡¥¯¥¿¡¼¤ä¼£ÎŤθ½¾õ¤Ê¤É¾Ü¤·¤¤¤³¤È¤Ï¤¢¤Þ¤ê¸¦µæ¤µ¤ì¤Æ¤¤¤Ê¤¤¤è¤¦¤Ç¤¹¡£
¤³¤Î¸¦µæ¤Ç¤Ï¥¦¥¹¥¿¡¼É±¡¡Ê¿Í¸ý478000¿Í¡Ë¤Ë¤ª¤±¤ë1999ǯ¤Î¥á¥Ç¥£¥«¥ë¥ì¥³¡¼¥É¤òÄ´ºº¤·¡¢¿¼ÉôÀÅÌ®·ìÀò¾É¤¢¤ë¤¤¤Ï¤½¤Î²ÄǽÀ¤¬¤¢¤ë¤È¿ÇÃǤµ¤ì¤¿¤â¤Î(¾å»è¡¢²¼»è¤È¤â¡Ë¤ò¥Ô¥Ã¥¯¥¢¥Ã¥×¤·¤ÆÄ´ºº¡¢¤½¤ì¤¾¤ì¤òÈæ³Ó¸¡Æ¤¤·¤Æ¤Þ¤¹¡£
ǯÎð¤ÇÄ´À°¤·¤¿Øí´µÎ¨¤Ï¾å»è¤Ç¤Ï16/10Ëü¿Í¡¢²¼»è91/10Ëü¿Í¤Ç¤ä¤Ï¤ê²¼»è¤ÎÀÅÌ®·ìÀò¾É¤ÎÊý¤¬Â¿¤¤¤è¤¦¤Ç¤¹¡£±Ö³ØÅª¤Ë¤Ï¾å»è¤ÎÀÅÌ®·ìÀò¾É¤ÎÊý¤¬¡¢Ç¯Îð¤¬Èæ³ÓŪ¼ã¤¯¡¢BMI¤¬¾®¤µ¤¤¿Í¤ËÈæ³ÓŪ¿¤¤¡¢ºÇ¶á¼ê½Ñ¤äÆþ±¡¤ò¤·¤¿¿Í¤Ë¿¤¤¤Ê¤É¤Î·¹¸þ¤¬¸«¤é¤ì¤¿¤è¤¦¤Ç¤¹¡£¤Þ¤¢¡¢¾Ü¤·¤¤¤³¤È¤ÏÏÀʸ¤òÆÉ¤ó¤Ç¤ß¤Æ¤¯¤À¤µ¤¤¡£
¤½¤ÎÃæ¤ÇÌܤò°ú¤¤¤¿¤Î¤¬¡¢ºÇ¶áÃæ¿´ÀÅÌ®¤òÆþ¤ì¤¿´µ¼Ô¤µ¤ó¤Ë¾å»è¿¼ÉôÀÅÌ®·ìÀò¾É¤¬Â¿¤¤¤È¸À¤¦¤³¤È¡£Ëõ¾Ã¤«¤éÃæ¿´ÀÅÌ®¤ËαÃÖ¤¹¤ë¥¿¥¤¥×¤Î¥«¥Æ¡¼¥Æ¥ë¤Ê¤é¤Ð¤½¤¦¤¤¤¦¤³¤È¤â¤¢¤ë¤À¤í¤¦¤È»×¤¦¤Î¤Ç¤¹¤¬¡¢¤½¤ì¤À¤±¤Ç¤Ê¤¯ÆâðôÀÅÌ®¤äº¿¹ü²¼ÀÅÌ®¤«¤éαÃÖ¤µ¤ì¤¿´µ¼Ô¤µ¤ó¤Ç¤âƱ¤¸¤°¤é¤¤¤ÎÉÑÅÙ¤Çȯ¾É¤·¤Æ¤¤¤ë¤Î¤¬°õ¾ÝŪ¤Ç¤·¤¿¡£Ã¯¤«¤¬¡¢¡Ö¤½¤¦¤¤¤¨¤Ð¡¢ICU¤ÇCV¤òÆþ¤ì¤Æ¤¤¤ë´µ¼Ô¤µ¤ó¤¬¤¿¤Þ¤ËÏÓ¤¬¼ð¤ì¤¿¤ê¤¹¤ë¤³¤È¤¬¤¢¤ë¤Ê¤¢¡Ä¡×¤Ê¤ó¤Æ¸À¤Ã¤Æ¤Þ¤·¤¿¡£
¾å»è¿¼ÉôÀÅÌ®·ìÀò¾É¤È¿ÇÃǤµ¤ì¤¿´µ¼Ô¤µ¤ó69¿Í¤Î¤¦¤Á¡¢43¿Í¤¬Ãæ¿´ÀÅÌ®¥«¥Æ¡¼¥Æ¥ë¤òÁÞÆþ¤µ¤ì¤Æ¤¤¤¿¤È¸À¤¦·ë²Ì¡£Éݤ¤¤Ç¤¹¤Í¡£
¤¿¤À¡¢¤É¤Î¤è¤¦¤Ê¼£ÎŤ¬¹Ô¤ï¤ì¤¿¤«¤ò¸«¤Æ¤ß¤ë¤È¡¢ÀѶËŪ¤Ê¼£ÎŤò¼õ¤±¤Æ¤¤¤ë¿Í¤Ï¤¢¤Þ¤ê¤ª¤é¤º¡¢¥Ø¥Ñ¥ê¥ó¤ä¥ï¡¼¥Õ¥¡¥ê¥ó¤ÎÅêÍ¿¤ò¼õ¤±¤¿¿Í¤Î³ä¹ç¤â²¼»è¤Î¿¼ÉôÀÅÌ®·ìÀò¾É¤ËÈæ¤Ù¤ÆÍ°Õ¤ËÄ㤤¡¢¤È¤¤¤¦¤³¤È¤Ç¤·¤¿¡£
¤È¤¤¤¦¤Î¤â¡¢¾å»è¤Î¿¼ÉôÀÅÌ®·ìÀò¾É¤Ï¤¢¤Þ¤ê½ÅÆÆ¤ÊÇÙºÉÀò¾É¤òµ¯¤³¤¹¤³¤È¤¬¾¯¤Ê¤¤¤é¤·¤¯²¼»è¤Ç¤Ï15¡ó¤Û¤É¤¬ÇÙºÉÀò¾É¤òȯ¾É¤¹¤ë¤Î¤ËÂФ·¡¢¾å»è¤Ç¤Ï1-2¡óÄøÅ٤ȤΤ³¤È¡£¤È¤Ï¤¤¤¨¡¢Á´¤¯µ¯¤³¤µ¤Ê¤¤¤ï¤±¤Ç¤Ï¤Ê¤¤¤Î¤Ç¤³¤ì¤«¤é¤â¸¦µæ¤¬É¬ÍפȤ«²¿¤È¤«¡Ä¡£
¸å´ü¸¦½¤°å¤Î¾¶ÆÉ²ñ¤À¤Ã¤¿¤Î¤Ç¤¹¤¬¡¢Â¾¤ÎÀèÀ¸Êý¤â¤¢¤Þ¤ê¤´Â¸ÃΤʤ«¤Ã¤¿¤è¤¦¤Ç¡¢¤ß¤ó¤Ê¤Î¿©¤¤¤Ä¤¤Ï¤«¤Ê¤ê¤Î¤â¤Î¤Ç¤·¤¿¡£¤É¤¦¤ä¤Ã¤ÆÃµ¤·¤Æ¤¤¿¤Î¤«ÃΤé¤Ê¤¤¤±¤É¡¢¤ä¤ë¤Ê¡Á¡£Ëͤ⼡¤Ï´èÄ¥¤ë¤¾¡¢¤È¡£
¥·¥¬¥Æ¥éÃæÆÇ¡¡Ciguatera Poisoning ¤Ë¤Ä¤¤¤ÆÄ´¤Ù¤Æ¤ß¤Þ¤·¤¿¡£Ê¸¸¥¤Ï¤¢¤Á¤³¤Á¤«¤é¤È¤Ã¤Æ¤¤Æ¤Þ¤¹¤¬¡¢Medline plus¤È¤¤¤¦¥µ¥¤¥È¤«¤é¤Î¤â¤Î¤ò¥Ù¡¼¥¹¤Ë¤·¤Æ¤Þ¤¹¡£
http://www.nlm.nih.gov/medlineplus/ency/article/002851.htm
¥·¥¬¥Æ¥éÃæÆÇ¤Î¸¶°ø¤Ï¥·¥¬¥È¥¥·¥ó¤È¤¤¤¦ÆÇÁǤǤ¢¤ë¡£¤³¤ÎÆÇÁǤϤ¢¤ë¼ï¤ÎÁôÎढ¤ë¤¤¤Ï±²ÊÜÌÓÁôÎà¤ÎÂÎÆâ¤Çºî¤é¤ì¤ë¡£¤½¤ÎÁôÎà¤ò¿©¤Ù¤¿¾®µû¤¬±øÀ÷¤µ¤ì¡¢¤½¤ì¤òÂ礤ʵû¤¬¿©¤Ù¤ë¤³¤È¤Ë¤è¤êÇ»½Ì¤¬¿Ê¤à¡£¤½¤ì¤ò¿Í´Ö¤¬¿©¤Ù¤ë¤Èɵ¤¤ò°ú¤µ¯¤³¤¹¡¢¤È¤¤¤¦¥á¥«¥Ë¥º¥à¤Ç¤¢¤ë¡£¥·¥¬¥È¥¥·¥ó¤ÏÇ®¤Ë°ÂÄê¤Ç¡¢¤¤¤«¤ËÄ´Íý¤·¤è¤¦¤È¤â¡¢¤½¤Îµû¤¬ÆÇ¤Ç±øÀ÷¤µ¤ì¤Æ¤¤¤ì¤ÐÃæÆÇ¾É¾õ¤òµ¯¤³¤¹¡£
±Ö³Ø¡Ë¥·¥¬¥Æ¥é±øÀ÷¤ÏÄ̾Æî¤Î²¹ÃȤʳ¤¤ÎÈæ³ÓŪÂ礤ʵû¤Ë¸«¤é¤ì¤ë¡£ºÇ¤â°ìÈÌŪ¤Ê¤Î¤Ï¡¢¥¹¥º¥¡¢¥Ï¥¿¡¢¥Õ¥¨¥À¥¤¤Ê¤É¤Îµû¤Ç¤¢¤ê¡¢¥¢¥á¥ê¥«¤Ç¤Ï¥Õ¥í¥ê¥À¤ä¥Ï¥ï¥¤¤Ê¤É¤Ç¿¤¯¸«¤é¤ì¤ë¡£
ÆüËܤǤϲÆì¤Ç¤Î¤ß¸«¤é¤ì¤Æ¤¤¤¿¤¬¡¢²¹ÃȲ½¤Ë¤è¤ê¼¡Âè¤Ë¤½¤Î±øÀ÷¤¬¹¤¬¤ê¤Ä¤Ä¤¢¤ë¡£ÆüËÜ¤Ç¤Î´í¸±µû¤Ï¥ª¥Ë¥«¥Þ¥¹¡¢¥É¥¯¥¦¥Ä¥Ü¡¢¥Õ¥¨¥À¥¤¡¢¥Ë¥»¥´¥¤¥·¤Ç¤¢¤ë¤¬¡¢¥«¥ó¥Ñ¥Á¡¢¥Ò¥é¥Þ¥µ¡¢¥¢¥µ¥ê¡¢¥Ð¥¤¥¬¥¤¡¢¥Û¥¿¥Æ¥¬¥¤¤Ç¤â¸«¤é¤ì¤ë¤³¤È¤¬¤¢¤ë¡£
ÀèÆü¡¢Âçºå¤Ç¥¤¥·¥¬¥¥À¥¤¤ò¿©¤Ù¤¿¤³¤È¤Ë¤è¤ëÃæÆÇ¤ÎÊó¹ð¤¬¤¢¤ê¡¢¤¦¤Á¤Îɱ¡¤Ë´µ¼Ô¤¬Íè¤ë²ÄǽÀ¤â¤¢¤ë¤«¤Ê¡Á¤È»×¤Ã¤ÆÄ´¤Ù¤Þ¤·¤¿¡£
¥·¥¬¥È¥¥·¥ó¤ò»ºÀ¸¤¹¤ëÁôÎà¤Ï¥µ¥ó¥´¤¬»àÌǤ·¤¿¤¢¤È¤Ë½é¤á¤ËȯÀ¸¤¹¤ëÁôÎà¤À¤½¤¦¤Ç¡¢¥µ¥ó¥´¤ÎÂçÎÌ»àÌǤ¬¸«¤é¤ì¤¿³¤°è¤Ç¤ÏȯÀ¸¤Î´í¸±À¤¬¹â¤¤¤½¤¦¤Ç¤¹¡£
ÁÇŨ¤Ê±§ÃèÁ¥ÃÏµå¹æ¤è¤ê
´í¸±À¤¬ºÇ¤â¹â¤Þ¤ë¤Î¤¬²Æ¾ì¤Ç¤¢¤ë¤¬¡¢ÁôÎबÂçÎ̤ËȯÀ¸¤¹¤ë»þ¤Ç¤¢¤ì¤Ð¤¤¤Ä¤Ç¤â¤½¤Î´í¸±À¤¬¤¢¤ë¡£¤·¤«¤·¡¢¶áǯ¤ÎÍ¢Á÷¾õ¶·¤ò¹Í¤¨¤ë¤È¡¢¤¢¤é¤æ¤ë¾ì½ê¤ÇȯÀ¸¤Î´í¸±À¤¬¤¢¤ë¡£
shellfish poisoning¤È¤¤¤¦Îà»÷¤Î¼À´µ¤¬¤¢¤ë¤¬¡¢¥¢¥é¥¹¥«¤ä¥Ë¥å¡¼¥¤¥ó¥°¥é¥ó¥É¤È¤¤¤Ã¤¿³¤°è¤Ç²Æ¾ì¤Ë¸ÂÄêŪ¤Ëµ¯¤¤ë¡£R¤ÎÉÕ¤«¤Ê¤¤·î¤Ë¥·¡¼¥Õ¡¼¥É¤ò¿©¤Ù¤ë¤Ê¡¢¤È¤¤¤¦¸ÀÍդϤ³¤ì¤ËͳÍ褹¤ë¤â¤Î¤Ç¤¢¤ë¡£
Àè½Ò¤Î¤è¤¦¤Ë¡¢¥·¥¬¥È¥¥·¥ó¤ÏÇ®¤Ë°ÂÄê¤Ç¡¢½¼Ê¬¤ËÇ®¤òÄ̤·¤¿µû¤Ç¤¢¤Ã¤Æ¤â¡¢¥·¥¬¥È¥¥·¥ó¤Ë±øÀ÷¤µ¤ì¤¿µû¤Ç¤¢¤ì¤ÐÃæÆÇ¾É¾õ¤òÄ褹¤ë¡£
¾É¾õ¡Ë¥·¥¬¥Æ¥éÃæÆÇ¤Î¾É¾õ¤Ïµû²ðÎà¤ò¿©¤Ù¤¿¸å2¡Á12»þ´Ö¸å¤ËÀ¸¤¸¤ë¡£½éȯ¾É¾õ¤È¤·¤Æ
¡¦ÓÒµ¤¡¢ÓÒÅÇ¡¡Ìó2Æü³¤¯
¡¦Ê¢ÄË
¡¦²¼Î¡¡¡½ÅÅ٤ǿåÍͤǤ¢¤ë
¤Ê¤É¤¬¤¢¤ê¡¢¤½¤Î¸å°Û¾ï¤Ê´¶³Ð¤Ë½±¤ï¤ì¤ë¡£
¡¦Æ¬ÄˡʺǤ⿤¤¡Ë
¡¦¶ÚÄ˾É
¡¦»õ¤¬È´¤±¤ë¡¢¤¢¤ë¤¤¤ÏÈ´¤±¤½¤¦¤Ê´¶³Ð
¡¦¸ý¹ÐÆâ¤Ë¶â°¤Î¤è¤¦¤ÊÌ£³Ð¤ò´¶¤¸¤ë
¡¦²¹³Ð¤ÈÎä³Ð¤¬º®Í𤹤ë¡Êɹ¤ò¾Æ¤±¤ë¤è¤¦¤Ë½ë¤¯´¶¤¸¤¿¤ê¡¢¥Þ¥Ã¥Á¤Î²Ð¤òÅà¤ê¤½¤¦¤ËÎ䤿¤¤¤È´¶¤¸¤¿¤ê¤¹¤ë¡Ë¥É¥é¥¤¥¢¥¤¥¹¥»¥ó¥»¡¼¥·¥ç¥ó
¡¦¿´Çï¿ô¤È·ì°µ¤¬Äã²¼¤¹¤ë¡Ê½Å¾É¤Î¾ì¹ç¡Ë
¥·¥¬¥Æ¥éÃæÆÇ¤òµ¿¤¦´µ¼ÔÍ×ÀÁ¤¬¤¢¤Ã¤¿¤é¡¦¡¦¡¦
¡¦Ç¯Îð¡¢Âνš¢Á´¿È¾õÂ֤ʤÉ
¡¦¿©¤Ù¤¿µû¤Î¼ïÎà
¡¦µû¤ò¿©¤Ù¤¿»þ¹ï
¡¦¿©¤Ù¤¿ÎÌ
¡¦µû¤ò¿©¤Ù¤¿¥ì¥¹¥È¥é¥ó
¤Ê¤É¤Î¾ðÊó¤ò³Îǧ¤·¤Þ¤·¤ç¤¦¡£
¼£ÎÅ¡ËÂоÉÎÅË¡¤¬Ãæ¿´¤Ç¤¹¡£
¡¦À©ÅǺÞÅêÍ¿
¡¦Í¢±Õ¤Ë¤è¤ëÁÓ¼º¿åʬ¤ÎÊäµë
¡¦¿À·Ð¾É¾õ¤ò¤È¤ë¤¿¤á¤Î¥Þ¥Ë¥È¡¼¥ëÅÀÅ©
ͽËɤΤ¿¤á¤Ë¤â¡¢´í¸±¤ÊµûÎà¤ÎÀÝ¿©¤òÈò¤±¤ë¡£ÃΤé¤Ê¤¤ÅÚÃϤÇÄà¤Ã¤¿µû¤ò¿©¤Ù¤ë¤È¤¤Ë¤ÏÃϸµ¤Ç¿©¤Ù¤é¤ì¤Æ¤¤¤ëµû¤«¤É¤¦¤«¤ò³Îǧ¤¹¤ë¡£¤¢¤ëÃÏÊý¤Ç¤ÏÌäÂê¤Ê¤¤µû¤¬¡¢¤¢¤ëÃÏÊý¤Ç¤ÏÆÇÀ¤ò»ý¤Ã¤Æ¤¤¤ë¤È¤¤¤¦¤³¤È¤¬¤¢¤ê¤¦¤ë¡£
ͽ¸å¡Ë
À¸Ì¿Í½¸å¤Ï¤è¤¤¡£¿À·Ð¾É¾õ¤Ï¿ô½µ´Ö³¤¯¡£»þ¤Ë1ǯ¤Û¤É³¤¯¤³¤È¤¬¤¢¤ë¡£ÆüËܤˤª¤±¤ë»àË´Îã¤Ï¤Ê¤¤¡£
Èï³²³ÈÂç¤òÈò¤±¤ë¤¿¤á¡¢µ¿¤¤¤Î¤¢¤ë¥ì¥¹¥È¥é¥ó¤ä¿©Æ²¤òÊÝ·ò½ê¤ËÏ¢Íí¤¹¤ëɬÍפ¬¤¢¤ê¤Þ¤¹¡¢°å»Õ¤ÎµÁ̳¤Ç¤¹¤Í¡£
Íî¤ÁÃ夤¤ÆÂн褹¤ì¤Ð¤Ê¤ó¤Æ¤³¤È¤Ï¤Ê¤¤¤ß¤¿¤¤¤Ç¤¹¤±¤É¡¢ÃΤé¤Ê¤¤¤È¤Ó¤Ã¤¯¤ê¤·¤Þ¤¹¤è¤Í¡¢¤è¤í¤·¤±¤ì¤Ð»²¹Í¤Ë¤·¤Æ¤¯¤À¤µ¤¤
¡£
Experience in not enough
Anesthesiology 2008;108:914-20
Ž¢·Ð¸³¤À¤±¤Ç¤ÏÉÔ½½Ê¬¡×¤È¤¤¤¦¥»¥ó¥»¡¼¥·¥ç¥Ê¥ë¤ÊÂê̾¤Ç¤¹¡£°·¤Ã¤Æ¤¤¤ë¥Æ¡¼¥Þ¤Ï¹ÅËì³°Ëã¿ì¤Ë¤Ä¤¤¤Æ¤Ç¤¹¤¬¡¢Â¾¤Î¼êµ»¤Ë´Ø¤·¤Æ¤â¶¦Ä̤¹¤ë¤â¤Î¤¬¤¢¤ë¤È»×¤¦¤Î¤Ç¥¢¥Ã¥×¤·¤Þ¤¹¡£
¹ÅËì³°Ëã¿ì¤Î¤è¤¦¤Ê̵¶ÝÎΰè¤Ë°Ûʪ¤òÁÞÆþ¤¹¤ë¤È¸À¤¦¼êµ»¤Ë¤Ï¾ï¤Ë2¤Ä¤ÎÌäÂêÅÀ¤¬¤Ä¤¤¤Æ²ó¤ê¤Þ¤¹¡£
°ì¤Ä¤Ï¸íÁÞÆþ¡¢¤â¤¦°ì¤Ä¤Ï´¶À÷¤Ç¤¹¡£¤³¤ì¤é¤òÈò¤±¤ë¤¿¤á¤Ë¤Ï¥Æ¥¯¥Ë¥Ã¥¯¤òË᤯¡¢Ìµ¶ÝÁàºî¤ò¿´¤¬¤±¤ë¤È¸À¤¦¤³¤È¤¬Èó¾ï¤Ë½ÅÍפˤʤê¤Þ¤¹¡£
ÅöÁ³¤Ê¤¬¤é¡¢¤Ï¤¸¤á¤«¤éξÊý¤È¤â¤¤Á¤ó¤È¤Ç¤¤ë¿Í¤Ï¤¤¤Ê¤¤¤ï¤±¤Ç¡¢¼êµ»¤¬Ì¤½Ï¤Ç¤¢¤ì¤Ð̵¶ÝÁàºî¾å¤Î¥ß¥¹¤âÅöÁ³Â¿¤¤¡¢¤È¸À¤¦¤³¤È¤Ï¼¨¤µ¤ì¤Æ¤¤¤ë¤ß¤¿¤¤¤Ç¤¹¡£¥È¥ì¡¼¥Ë¥ó¥°¤Ë¤è¤ê¼êµ»¤¬¾å㤷¤Æ¤¤¤¯¤Ë¤Ä¤ì¡¢Ìµ¶ÝÁàºî¤â³Î¼Â¤Ë¹Ô¤¨¤ë¤è¤¦¤Ë¤Ê¤ë¡¢¤È¤¤¤¦¤³¤È¤Ïͽ¬¤µ¤ì¤ë¤Î¤Ç¤¹¤¬¡¢¤½¤ÎÁê´Ø¤òÌÀ³Î¤Ë¼¨¤·¤¿¸¦µæ¤Ï¤Ê¤¤¡¢¤È¤¤¤¦¤³¤È¤Ç¤½¤ì¤ò¾ÚÌÀ¤·¤è¤¦¤È¸À¤¦¼ñ¸þ¤Ç¤¹¡£
11¿Í¤Î¥ì¥¸¥Ç¥ó¥È¤ÎÀèÀ¸¤òÂоݤˡ¢¹ÅËì³°Ëã¿ì¤ò£±¤«¤é¶µ¤¨¹þ¤ó¤Ç¹Ô¤¤Þ¤¹¡£¼ÂºÝ¤Ë¼êµ»¤ò¹Ô¤¦Ãʳ¬¤Ë¤Ê¤Ã¤¿¤é1ÎãÌÜ¡¢30ÎãÌÜ¡¢90ÎãÌܤǤ½¤ì¤¾¤ìÁÞÆþ¼êµ»¤ÎÍͻҤò¥Ó¥Ç¥ª»£±Æ¡¢¤½¤ì¤é¤ò¥·¥ã¥Ã¥Õ¥ë¡£²¿ÎãÌܤ«¤òÃΤ餵¤ì¤Æ¤¤¤Ê¤¤É¾²Á¼Ô¤Ë¡¢¥Á¥§¥Ã¥¯¥ê¥¹¥È¤Ë´ð¤Å¤¤¤¿É¾²Á¤ò¤·¤Æ¤â¤é¤¤¡¢ÆÀÅÀ²½¤·¤Þ¤¹¡£
·ë²Ì¡¢¥¹¥¥ë¤Ë´Ø¤¹¤ë¥¹¥³¥¢(Manual skill checklist total score)¤Ï¾ÉÎã¤ò½Å¤Í¤ë¤´¤È¤Ë¾å¤¬¤Ã¤Æ¤¤¤¤Þ¤¹¡£Áê´Ø·¸¿ô0.84¡¢p<0.0001¤È¤¤¤¦¶¯¤¤Áê´Ø¤ò¼¨¤·¤Þ¤¹¡£Global rating scale¤È¤¤¤¦¤³¤ì¤â¥¹¥¥ë¤Ë´Ø¤¹¤ë¥¹¥³¥¢¤âÁê´Ø·¸¿ô0.70¡¢p<0.0001¤È¤Ê¤ê¡¢·Ð¸³¤ò½Å¤Í¤ë¤´¤È¤Ë¥Æ¥¯¥Ë¥Ã¥¯¤¬¾å㤹¤ë¤³¤È¤¬¤è¤¯Ê¬¤«¤ë·ë²Ì¤Ç¤·¤¿¡£
¤¿¤À¤·¡¢Ìµ¶ÝÁàºî¤Ë´Ø¤¹¤ë¥¹¥³¥¢¤Ï¤³¤ì¤ÈÁ´¤¯°Û¤Ê¤ê¡¢Áê´Ø·¸¿ô0.23¡¢p=0.2097¤È¤¤¤¦»´Øë¤¿¤ëÍÍÍ¡£Ìµ¶ÝÁàºî¤Ï·Ð¸³¤ò½Å¤Í¤Æ¤â¾å㤷¤Ê¤¤¤È¸À¤¦·ë²Ì¤Ç¤·¤¿¡£
¤Ê¤¼¡¢¤³¤Î¤è¤¦¤Ê·ë²Ì¤Ë¤Ê¤Ã¤¿¤Î¤«¡£É®¼Ô¤Ï¶µ¤¨¤ë¦¡¢¶µ¤ï¤ë¦ξÊý¤Î¸¶°ø¤ò»ØÅ¦¤·¤Æ¤ª¤ê¤Þ¤¹¤¬¡¢ºÇ½ªÅª¤Ë¤Ï¶µ¤¨¤ë¦¤Î¿Í´Ö¤¬¥ì¥¸¥Ç¥ó¥È¤ÎÃ챤äÍý²òÅÙ¤ò¤¤Á¤ó¤ÈÇİ®¤Ç¤¤Æ¤ª¤é¤º¡¢Å¬ÀÚ¤ÊÃ챤ò¤Ä¤±¤µ¤»¤ë¤³¤È¤¬¤Ç¤¤Ê¤«¤Ã¤¿¤«¤é¡¢¤È¤·¤Æ¤¤¤Þ¤¹¡£
¤â¤Á¤í¤ó¡¢¹ÅËì³°Ëã¿ì¤ò¶µ¤¨¤ë½é´üÃʳ¬¤Ç̵¶ÝÁàºî¤ä¤½¤Î½ÅÍ×À¤Ë¤Ä¤¤¤Æ¤Î¹Ö½¬¤â¹Ô¤ï¤ì¤ë¤è¤¦¤Ê¤Î¤Ç¤¹¤¬¡¢¤½¤ÎÁ°¤ÎÃʳ¬¡¢¥á¥Ç¥£¥«¥ë¥¹¥¯¡¼¥ë¤Ç¤Ï¤½¤¦¤¤¤Ã¤¿À¶·éÁàºî¤Î»ØÆ³¤Ë½ÅÅÀ¤¬ÃÖ¤«¤ì¤Æ¤¤¤Ê¤¤¤³¤È¤â¤¢¤ê¡¢¶µ¤¨¤Æ¤â¿È¤Ë¤Ä¤«¤Ê¤¤¤Î¤Ç¤Ï¤Ê¤¤¤«¡¢¤È¤Î¤³¤È¤Ç¤¹¡£
Î×¾²¤Î¾ì¤Ç¤Î¥È¥ì¡¼¥Ë¥ó¥°¤Ç¤â¶µ¤¨¤ë¦¤Ï¥Æ¥¯¥Ë¥Ã¥¯¤¬Ãæ¿´¤Ç¡¢Ìµ¶ÝÁàºî¤ÏÃΤäƤ¤¤ë¤â¤Î¤È¤µ¤ì¤ë¤«¡¢¾ì¹ç¤Ë¤è¤Ã¤Æ¤Ï¤ä¤ë¤¦¤Á¤Ë³Ð¤¨¤í¤È¸À¤¦¤è¤¦¤Ê¹Í¤¨Êý¤Î¤È¤³¤í¤â¤¢¤ë¤È¡£¼ª¤¬Äˤ¤¤Ç¤¹¤Í¡¢»ä¤â¤½¤¦¤¤¤¦¤È¤³¤í¤¬¤¢¤ë¤«¤â¤·¤ì¤Þ¤»¤ó¡£¤½¤â¤½¤â¡¢¶µ¤¨¤ë¦¤Ë¤¤Á¤ó¤È¤·¤¿À¶·éÁàºî¤ÎÃ챤¬¤¢¤ë¤«¤È¤¤¤¦¤Î¤âÌäÂê¤À¤È»×¤¦¤ó¤Ç¤¹¡£À¶·éÁàºî¤Ë´Ø¤·¤Æ¡¢´Ç¸îÉØ¤µ¤ó¤ËÃí°Õ¤ò¼õ¤±¤ë¤³¤È¤â¤¢¤ë¤·^^;¡£º£²ó¤Ï¥ì¥¸¥Ç¥ó¥È¤¬ÂоݤǤ¹¤¬¡¢¥¹¥¿¥Ã¥Õ¥É¥¯¥¿¡¼¤â¸ò¤¨¤¿¸¦µæ¤ò¤¹¤ë¤È¤â¤Ã¤È¤¹¤´¤¤·ë²Ì¤¬½Ð¤ë¤«¤â¤Í¡£
ÆÉ¤ß½ª¤ï¤Ã¤¿¤¢¤È¤ÎƤÏÀ¤Ç¤â¤½¤Î¤è¤¦¤ÊÏ䬽Фޤ·¤¿¡£¼«Ê¬¤Î¼êµ»¤â°ìÅÙ¥Á¥§¥Ã¥¯¤·¤Æ¤â¤é¤¤¤¿¤¤¤â¤Î¤À¡¢¤ÈÉôĹ¡£
̵¶ÝÁàºî¤Ë´Ø¤¹¤ëÃμ±¤Ï¤Ê¤«¤Ê¤«¿È¤Ë¤Ä¤¤Ë¤¯¤¤¤ß¤¿¤¤¤Ç¤¹¡¢¤ß¤Ê¤µ¤ó¤â¤ªµ¤¤ò¤Ä¤±¤Æ¡£
Home use of automated external defibrillators for sudden cardiac arrest
N Engl J Med. 2008 Apr 24;358(17):1853-5
ºÇ¶á¤Ç¤Ï¿Í¤¬Âô»³½¸¤Þ¤ë¾ì½ê¤Ë¤Ïɬ¤º¤È¤¤¤Ã¤Æ¤¤¤¤¤Û¤ÉAED¤¬ÃÖ¤¤¤Æ¤¢¤ê¤Þ¤¹¤¬¡¢É±¡°Ê³°¤Ç¿´Ää»ß¤¬µ¯¤³¤ë¾ì½ê¤È¤·¤Æ¤â¤Ã¤È¤â°ìÈÌŪ¤Ê¤Î¤Ï¼«Âð¤Ç¤·¤ç¤¦¡£
¤³¤ÎÏÀʸ¤Ï¼«Âð¤ËAED¤òÃÖ¤¤¤¿¤é»à˴Ψ¤¬¸º¾¯¤¹¤ë¤«¡¢¤È¤¤¤¦¤³¤È¤ò¸¡Æ¤¤·¤Æ¤¤¤Þ¤¹¡£
Á°Êɹ¼ºÉ¤Î´û±ý¤¬¤¢¤ê¡¢Ëä¤á¹þ¤ß·¿½üºÙư´ï¤¬Æþ¤Ã¤Æ¤¤¤Ê¤¤Ìó7000¿Í¤ò2·²¤Ëʬ¤±¡¢°ìÊý¤ÏAED¤òÁõÃ夷¤Æ¤«¤éµßµÞ¼Ö¤ò¸Æ¤Ó¡¢CPR¤ò¹Ô¤¦¡£¥³¥ó¥È¥í¡¼¥ë·²¤Ï¤½¤Î¤Þ¤ÞµßµÞ¼Ö¤ò¸Æ¤Ó¡¢CPR¤ò¹Ô¤¦¡£
·ë²Ì¤Ï»à˴Ψ¤Ëº¹¤Ï¤Ê¤·¡¢¤È¤Î¤³¤È¤Ç¤¹¡£
º£AED¤ÏÇä¤ì¤ËÇä¤ì¤Æ¤¤¤ë¤È»×¤¤¤Þ¤¹¤¬¡¢¼«Âð¤ËÃÖ¤¤¤Æ¤â¤¢¤Þ¤ê°ÕÌ£¤¬¤Ê¤¤¤è¤¦¤Ç¤¹¡£
Management of in-flight medical emergencies
Anesthesiology 2008;108:749-55
À¤³¦Ãæ¤ÇÈô¹Ôµ¡¤ËÅо줹¤ë¿Í¤Î¿ô¤Ïǯ´Ö20²¯¿Í¤Ë¤â¾å¤ë¤½¤¦¤Ç¤¹¡£¤Þ¤¿¡¢ºÇ¶á¤Î·¹¸þ¤È¤·¤Æ¾èµÒ¤Î¹âÎ𲽤¬¸«¤é¤ì¤ë¤½¤¦¤Ç¡¢»ýɤ¬¤¢¤Ã¤¿¤ê´Ä¶¤ÎÊѲ½¤ËŬ±þ¤Ç¤¤Ê¤«¤Ã¤¿¤ê¤Ç¡¢¶ñ¹ç¤¬°¤¯¤Ê¤ë¿Í¤â¿¤¤¤È¤«¡£¤Þ¤¿¡¢¥¨¥¢¥Ð¥¹A380¤ß¤¿¤¤¤Ë¾èµÒ¤Î¿ô¤¬800¿Í°Ê¾å¤Ê¤ó¤Æ¤Î¤â¤¢¤ë¤Î¤Ç¡¢µ¡Æâ¤ÎµÞÉ¿ͤËÁø¶ø¤¹¤ëµ¡²ñ¤ÏÁý¤¨¤Ä¤Ä¤¢¤ë¤È¤Î¤³¤È¡£
»ä¤â°ìÅÙ¤À¤±¡¢¡Öµ¡Æâ¤Ë¤ª°å¼ÔÍͤϤª¤é¤ì¤Þ¤»¤ó¤«¡©¡×¤È¤¤¤¦¾ìÌ̤ˤ¢¤Ã¤¿¤³¤È¤¬¤¢¤ê¤Þ¤¹¡£¤Þ¤¢¡¢¤½¤Î»þ¤Ï³ØÀ¸¤À¤Ã¤¿¤Î¤Ç¡¢ÅöÁ³°åÎŹ԰٤ϤǤ¤Ê¤«¤Ã¤¿¤Î¤Ç̵»ë¤Ç¤·¤¿¡£¤¢¤ì¤«¤é¤½¤Î¤è¤¦¤Ê¾ìÌ̤˽Ф¯¤ï¤·¤¿¤³¤È¤Ï̵¤¤¤Î¤Ç¤¹¤¬¡¢º£¤Ê¤é¤É¤¦¤¹¤ë¤À¤í¡©
¤â¤Á¤í¤ó¡¢µ¡Æâ¥¹¥¿¥Ã¥Õ¤Ë¤ÏµßµÞ°åÎŤËÂФ¹¤ë¤¢¤ëÄøÅ٤Υȥ졼¥Ë¥ó¥°¤ÏµÁ̳ÉÕ¤±¤é¤ì¤Æ¤¤¤ë¤è¤¦¤Ê¤Î¤Ç¤¹¤¬¡¢¤³¤ÎÏÀʸ¤Ç¤Ï¥¢¥á¥ê¥«¤ÎϢˮ¹Ò¶õ´ÉÍý¶É¤¬Äê¤á¤¿µ¬Äê¤Ë¥¹¥Ý¥Ã¥È¤ò¤¢¤Æ¡¢¹Ò¶õµ¡Æâ¤ÎµßµÞ°åÎŤˤĤ¤¤Æ²òÀ⤷¤Æ¤Þ¤¹¡£
¤½¤ÎÉÑÅ٤ˤĤ¤¤Æ¤Ç¤¹¤¬¡¢¥¢¥á¥ê¥«¹ç½°¹ñ¤Ë¤ª¤¤¤Æ1996ǯ¤«¤é1997ǯ¤ÇÄ´¤Ù¤¿¤È¤³¤í¤Ë¤è¤ë¤È¡¢Æþ±¡¤òɬÍפȤ¹¤ë¤è¤¦¤Êµ×É¿ͤÎȯÀ¸¤Ï1132·ï¡¢1ÆüÅö¤¿¤ê13¿Í¡¢39600¿Í¤Ë1¿Í¤°¤é¤¤¤À¤½¤¦¤Ç¤¹¡£¤¦¡¼¤ó¡¢¤½¤¦¹Í¤¨¤ë¤È·ë¹½¤ÊÉÑÅ٤Ǥ¹¤Í¡£
Áʤ¨¤Ç¿¤¤¤â¤Î¤Ï1°Ì¤¬¼º¿À¡Ê15%)¡¢¤Ä¤¤¤Ç³°½ý(12%)¡¢°ßIJ¾ã³²(12%)¡¢¸ÆµÛ´ï·Ï¡Ê11%)¡¢Àº¿À¼À´µ(3.5%)¤Ê¤É¤Ê¤É¡£¿´¼À´µ¤¬°Õ³°¤Ë¾¯¤Ê¤¤¤È»×¤¤¤Þ¤·¤¿¤¬¡¢¼º¿À¤ä¸ÆµÛ´ï·Ï¥¤¥Ù¥ó¥È¤ÎÃæ¤Ë´Þ¤Þ¤ì¤Æ¤¤¤ë¤ó¤Ç¤·¤ç¤¦¤«¡©
¤³¤ì¤é¤Î¼À´µ¤ò°ú¤µ¯¤³¤¹Í×°ø¤È¤·¤Æ
1.Äã»ÀÁÇ¡¡Èô¹ÔÃæ¤Ïµ¤°µ¤ÎÄã²¼¤Ë¤è¤ê»ÀÁÇʬ°µ¤¬Äã²¼¤¹¤ë¤½¤¦¤Ç¹âÅÙ2400m¤°¤é¤¤¡ÊµÒ¼¼¤Îµ¤°µ¤ÏÂçÂιâÅÙ1800¡Á2400m¤ËÁêÅö¤¹¤ë°µ¤ËÊݤ¿¤ì¤Æ¤¤¤ë¤½¤¦¤Ç¤¹¡Ë¤Ç¤ÏSpO2¤Ï89%¤°¤é¤¤¤ËÄã²¼¤¹¤ë¤é¤·¤¤¤è¡£
2.µ¤ÂΤÎËÄÄ¥¡¡
3.µÒ¼¼¤Î¶õµ¤¤Î¼Á¡¡
4.¿¼ÉôÀÅÌ®·ìÀò
¤Ê¤É¤¬µó¤²¤é¤ì¤Æ¤Þ¤·¤¿¡£
¤½¤Î¾¡¢µ¡Æâ¤ËÀߤ±¤é¤ì¤Æ¤¤¤ëemergency medical kit¤äfirst aid kit¤Î¥ê¥¹¥È¤â·ÇºÜ¤µ¤ì¤Æ¤ª¤ê¤Þ¤·¤¿¡£¤Þ¤¢¡¢Èô¹Ôµ¡¤Ë¾è¤»¤é¤ì¤ëÎ̤ˤϸÂÅÙ¤¬¤¢¤ê¤Þ¤¹¤·¡¢¤³¤ì¤°¤é¤¤¤«¤Ê¤È»×¤¤¤Þ¤·¤¿¡£¶½Ì£¤Î¤¢¤ëÊý¤ÏÆÉ¤ó¤Ç¤ß¤Æ¤Ï¤É¤¦¤Ç¤·¤ç¤¦¤«¡£
Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components
Crit Care Med 2007;35:1645-1648
Í¢·ì¤Ë´ØÏ¢¤·¤¿Çپ㳲 Transfusion-related acute lung injury(TRALI)¤Ïº£¤ä¥¢¥á¥ê¥«¤Ç¤ÎÍ¢·ì´ØÏ¢»àË´¤Î¸¶°ø¤Î¥ï¡¼¥¹¥È1¤Ë¤Ê¤Ã¤Æ¤¤¤ë¤½¤¦¤Ç¤¹¡£
¤½¤ÎȯÀ¸¤Ë¤Ï¹³Çò·ìµå¹³ÂΤ¬´ØÍ¿¤·¤Æ¤¤¤ë¤é¤·¤¯¡¢¥¢¥á¥ê¥«¤Î·ì±Õ¥Ð¥ó¥¯¶¨²ñ¤Ç¤Ï¤½¤Î¤è¤¦¤Ê¹³ÂΤò»ý¤Ã¤Æ¤¤¤ë²ÄǽÀ¤Î¤¢¤ë¥É¥Ê¡¼¡¢ÆÃ¤Ë½÷ÀͳÍè¤ÎFFP¤ä·ì¾®ÈÄÀ½ºÞ¤ÎÂçÎÌ»ÈÍѤòÈò¤±¤ë¤è¤¦¤Ë´«¹ð¤·¤Æ¤¤¤ë¤é¤·¤¤¡£
¤Ï¤Ã¤¤ê¤È¤Ï½ñ¤¤¤Æ¤¢¤ê¤Þ¤»¤ó¤Ç¤·¤¿¤¬¡¢½÷À¤Ï½Ð»º¤Ë¤è¤ê¹³Çò·ìµå¹³ÂΤ¬»ºÀ¸¤µ¤ì¤ë¤«¤é¡¢¤È¤¤¤¦¤Î¤¬Íýͳ¤Î¤è¤¦¤Ç¡£
¤³¤Î¸¦µæ¤Ç¤ÏICU¤ËÆþ¼¼¤¹¤ë¤è¤¦¤Ê½Å¾É´µ¼Ô¤òÂоݤˡ¢¡ÃËÀͳÍè¤Î·ì±ÕÀ½ºÞ¤Î¤ß¤òÍ¢·ì¤µ¤ì¤¿´µ¼Ô·²¤È¡¢¢½÷ÀͳÍè¤Î¤ß¤¢¤ë¤¤¤ÏÃËÀ½÷ÀξÊýͳÍè¤Î·ì±ÕÀ½ºÞ¤òÍ¢·ì¤µ¤ì¤¿´µ¼Ô·²¤ò¥Ô¥Ã¥¯¥¢¥Ã¥×¤·¡¢Èæ³Ó¤·¤Æ¤¤¤Þ¤¹¡£
¿·¤¿¤ÊALI¤Îȯ¾É¿ô¤Ë¤Ï°ã¤¤¤¬¸«¤é¤ì¤Ê¤«¤Ã¤¿¤è¤¦¤Ç¤¹¤¬¡¢Í¢·ì¸å¤ÎP/FÈæ¡ÊPaO2/FiO2)¤ÎÃͤϡ¤ÎÊý¤¬Í°Õ¤Ë¹â¤«¤Ã¤¿¤½¤¦¤Ç¤¹¡£¤Þ¤¿¡¢¿Í¹©¸ÆµÛ´ï¥Õ¥ê¡¼¤Î´ü´Ö¤ä±¡Æâ»à˴Ψ¤â¾¯¤Ê¤¤·¹¸þ¤¬¡£
¤¿¤À¡¢£î¿ô¤¬¾¯¤Ê¤¯¡¢Â絬Ìϸ¦µæ¤È¤Þ¤Ç¤Ï¸À¤¨¤Ê¤¤¤Î¤Ç·ëÏÀ¤ò½Ð¤¹¤Î¤Ï¤Á¤ç¤Ã¤ÈÁᤤ¤è¤¦¤Êµ¤¤â¤·¤Þ¤¹¡£¤³¤ó¤Ê·ëÏÀ¤¬½Ð¤ì¤Ð¡¢·ì±Õ¥»¥ó¥¿¡¼¤äÍ¢·ìÉô¤ËÃíʸ¤ò¤Ä¤±¤ë°å»Õ¤¬½Ð¤Æ¤¯¤ë²ÄǽÀ¤¬¤¢¤ê¤Þ¤¹¤â¤ó¤Í¡£
°Æ¤ÎÄê¡¢ÉôĹ¡Ê½÷À¡Ë¤Ë¤Ï¡Ö¤»¤¤¤¼¤¤¥È¥ê¥Ó¥¢¤È¤·¤ÆÊ¹¤¤¤Æ¤ª¤¯¡×¤Ê¤É¤È¸À¤ï¤ì¤Æ¤·¤Þ¤¤¤Þ¤·¤¿¡£
¡Êº£Æü¤â¥ß¥¹¥Á¥ç¥¤¥¹¡©¡Ë
Serum Vasopressin concentrations in critically ill patients
Crit care med 2006;34:293-299
ÇÔ·ì¾ÉÀ¥·¥ç¥Ã¥¯¤ò¤Ï¤¸¤á¤È¤¹¤ë·ì´É³ÈÄ¥À¥·¥ç¥Ã¥¯¤Î»þ¤Ë¤Ï»þ¤È¤·¤Æ¥Ð¥½¥×¥ì¥Ã¥·¥ó¤¬Í¸ú¤Ç¤¢¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¤¬¡¢¤³¤Î¸¦µæ¤Ç¤ÏICU¤ËÆþ¼¼¤¹¤ë´µ¼Ô¤Ç¤Ï·ìÀ¶¥Ð¥½¥×¥ì¥Ã¥·¥óÇ»ÅÙ¤¬¤É¤Î¤è¤¦¤Ë¤Ê¤Ã¤Æ¤¤¤ë¤«¤òÄ´ºº¤·¤Æ¤ª¤ê¤Þ¤¹¡£
ÂоݤÏ239¿Í¤ÎICUÆþ¼¼´µ¼Ô¤È·ò¾ï¥Ü¥é¥ó¥Æ¥£¥¢70¿Í¡£Æþ¼¼¤«¤é24»þ´Ö¸å¤Î¥Ð¥½¥×¥ì¥Ã¥·¥óÇ»ÅÙ¤ò¬Äꤹ¤ë¤È¤È¤â¤Ë¡¢Çطʰø»Ò¤ä·ì¹ÔưÂÖ¡¢½Û´ÄÊä½õÌô¤Î»ÈÍѾõ¶·¤Ê¤É¤òÄ´¤Ù¤Æ¤ª¤ê¤Þ¤¹¡£
»ä¤Î¥¤¥á¡¼¥¸¤È¤·¤Æ¤Ï¥Ð¥½¥×¥ì¥Ã¥·¥ó¤ÎÅêÍ¿¤Ë¤è¤ê·ì°µ¾å¾º¤¬ÆÀ¤é¤ì¤ë¤È¤¤¤¦»ö¼Â¤«¤é¤â¡¢½Å¾É´µ¼Ô¤Ç¤Ï·ìÃæ¥Ð¥½¥×¥ì¥Ã¥·¥óÇ»ÅÙ¤ÏÄã²¼¤·¤Æ¤¤¤ë¤Ë°ã¤¤¤Ê¤¤¡¢¤È»×¤Ã¤¿¤Î¤Ç¤¹¤¬Ž¥Ž¥Ž¥
·ë²Ì¤Ï¤½¤ì¤ËÈ¿¤·¡¢ICUÆþ¼¼´µ¼Ô¤Ç¤Ï²¡¤·¤Ê¤Ù¤Æ¹â¤¯·ìÀ¶¥Ð¥½¥×¥ì¥Ã¥·¥óÇ»ÅÙ¤ÎÊ¿¶ÑÃͤÏ10Çܤۤɤ⺹¤¬¤¢¤Ã¤¿¤½¤¦¤Ç¤¹¡£ÆÃ¤Ë¿´Â¡¼ê½Ñ¸å¤Î´µ¼Ô¤ÎÊ¿¶ÑÃͤϷò¾ï¥Ü¥é¥ó¥Æ¥£¥¢¤ÎÃͤÎ20ÇܶᤤǻÅ٤Ǥ¢¤Ã¤¿¤È¤«¡£¤Þ¤¿¡¢ÃËÀ¤è¤ê¤â½÷À¤ÎÊý¤¬¥Ð¥½¥×¥ì¥Ã¥·¥óÇ»Å٤Ϲ⤯¡¢ICUÂںߴü´Ö¤¬Ä¹¤¤¤Û¤É·ìÃæÇ»ÅÙ¤ÏÄã²¼¤¹¤ë¡¢¤È¸À¤¦¤è¤¦¤Ê·¹¸þ¤â¸«¤é¤ì¤¿¤é¤·¤¤¡£
°Õ³°¤Ë¤â·ì¹ÔưÂ֤Υѥé¥á¡¼¥¿¤È¥Ð¥½¥×¥ì¥Ã¥·¥óÇ»Å٤δ֤ˤÏÁê´Ø´Ø·¸¤Ï¸«¤é¤ì¤º¡¢·ìÃæ¥Ð¥½¥×¥ì¥Ã¥·¥óÇ»ÅÙ¤¬¹â¤¤¤«¤é·ì°µ¤¬¹â¤¤¡¢¤È¤¤¤¦¤â¤Î¤Ç¤â¤Ê¤µ¤½¤¦¤Ç¤¹¡£¤Ê¤ª¡¢ÅöÁ³¤Î¤³¤È¤Ê¤¬¤é¤³¤Î¸¦µæ¤Ç¤Ï³°¤«¤é¥Ð¥½¥×¥ì¥Ã¥·¥ó¤òÅêÍ¿¤·¤¿¤è¤¦¤Ê´µ¼Ô¤Ï½ü³°¤µ¤ì¤Æ¤¤¤Þ¤¹¤¬¡¢¤½¤Î¤è¤¦¤Ê¾ì¹ç¤Î·ìÃæ¥Ð¥½¥×¥ì¥Ã¥·¥óÇ»Å٤Ϥâ¤Ã¤È¤â¤Ã¤È¹â¤¯¤Ê¤ë¤ß¤¿¤¤¤Ç¤¹¡£
¥Ð¥½¥×¥ì¥Ã¥·¥ó¤ÎÍÑÅӤäÆÂ¿¤¤¤Ç¤¹¤è¤Í¡£ÉؿͲʤǤâ»ÒµÜ¶Ú¼ð³Ë½Ð½Ñ¤ò¤¹¤ë¤È¤¡¢½Ð·ìÎ̤ò¸º¤é¤¹ÌÜŪ¤Ç¶Ú¼ðÉÕ¶á¤Ë¥Ð¥½¥×¥ì¥Ã¥·¥ó¤òľÀÜÃí¼Í¤·¤¿¤ê¤â¤·¤Þ¤¹¤·¡¢ÌçÌ®°µ¤ò²¼¤²¤ë¤Î¤Ë¤â¡¢¿´ÇÙÁÉÀ¸¤Î¾ì¤Ë¤ª¤¤¤Æ¤â¡¢Ç¾³°²Ê¼ê½Ñ¤Î¸å¤Ê¤É¤Ë¤âޥޥޥ¡£
¤Ê¤«¤Ê¤«¥á¥«¥Ë¥º¥à¤ÏÊ£»¨¤½¤¦¤Ç¤¹¤¬¡¢ÌÌÇò¤¤Êª¼Á¤Ç¤¹¤Í¡£
Cardiac arrests associated with hyperkalemia during red blood cell transfusion: A case series
Anesth Analg 2008;106:1062-9
Í¢·ì¥Ñ¥Ã¥¯¤ÎÃæ¤Ç¤Ï¡¢»þ´Ö¤È¤È¤â¤Ë³èư¤ÎÄã²¼¤·¤¿ÀÖ·ìµå¤«¤é¥«¥ê¥¦¥à¤¬Êü½Ð¤µ¤ì¤Æ¤¤Þ¤¹¡£¤½¤ì¤Ë¤è¤ë¿´Ää»ß¤Ë¤Ä¤¤¤ÆÄ´¤Ù¤¿¸¦µæ¤Ç¤¹¡£
1988ǯ¤«¤é2006ǯ¤Î´Ö¤Ë¥á¥¤¥è¡¼¥¯¥ê¥Ë¥Ã¥¯¤Î¥Ç¡¼¥¿¥Ù¡¼¥¹¤ËÅÐÏ¿¤µ¤ì¤¿Í¢·ì´ØÏ¢¤Î¹â¥«¥ê¥¦¥à·ì¾É¤Ë¤è¤ë¿´Ää»ß¤È¿ÇÃǤµ¤ì¤¿¾ÉÎã16Îã¤ò¸¡Æ¤¤·¤Æ¤ª¤ê¤Þ¤¹¡£°Õ³°¤Ë¿¤¤¤Ê¤È»×¤Ã¤¿¤â¤Î¤Î¡¢¤è¤¯¹Í¤¨¤ë¤È¡¢¥á¥¤¥è¡¼¥¯¥ê¥Ë¥Ã¥¯¤Ã¤Æ3¤Ä¤Î½£¤Ë¤¢¤ê¡¢¤½¤Î°ì¤Ä¤À¤±¤Ç¤âǯ´Ö¼ê½Ñ·ï¿ô50000·ï¤È¤«¤¢¤ë¤é¤·¤¤¤Î¤Ç¡¢¤½¤ì¤ò¹Í¤¨¤ë¤È¾¯¤Ê¤¤¤È¤â¸À¤¨¤ë¤Î¤Ç¤·¤ç¤¦¤«¡©
16Îã¤Î¤Û¤È¤ó¤É¤¬´â¡¢Âç·ì´É¡¢³°½ý¤Î¼ê½ÑÃæ¤Î¿´Ää»ß¤Ç¡¢¿´Ää»ß»þ¤Ë¬Äꤷ¤¿¥«¥ê¥¦¥à¤ÎÊ¿¶ÑÃͤÏ7.2mEq/L¡£¤Û¤È¤ó¤É¤¹¤Ù¤Æ¤Î´µ¼Ô¤Ï¥¢¥·¥É¡¼¥·¥¹¡¢¹â·ìÅü¡¢Ä㥫¥ë¥·¥¦¥à¡¢ÄãÂβ¹¤ò¹çÊ»¤·¤Æ¤¤¤¿¤½¤¦¤Ç¤¹¡£
¤Þ¤¿¡¢14¿Í¤ÏÃæ¿´ÀÅÌ®¤«¤éÍ¢·ì¤ò¼õ¤±¤Æ¤¤¤¿¤È¸À¤¦¤Î¤â°Õ³°¤Ç¤·¤¿¡£ËͤÏÃæ¿´ÀÅÌ®¤«¤éÍ¢·ì¤ò¤¹¤ë¡¢¤È¤¤¤¦½¬´·¤¬Ìµ¤¤¤Î¤Ç¡£±¡ÆâÀ¸Â¸Î¨¤Ï12.5%¡£¤ä¤Ï¤êͽ¸å¤Ï¸·¤·¤¤¤è¤¦¤Ç¤¹¡£
¶½Ì£¿¼¤«¤Ã¤¿¤Î¤¬¡¢Í¢·ì¤ÎÊݸ´ü´Ö¤È¾åÀ¡¤ß±Õ¡Êsupernatant)¤Î¥«¥ê¥¦¥àÇ»Å٤Ȥδط¸¤ò¼¨¤·¤¿figure¤Ç¡¢¤½¤ì¤Ë¤è¤ë¤ÈºÎ·ì¸å7Æü°ÊÆâ¤Î¥«¥ê¥¦¥àÇ»ÅÙ¤Ï19mEq/L¤Ç¤¹¤¬¡¢8¡Á14Æü¤Ë¤Ê¤ë¤È31mEq/L¡¢15¡Á28Æü¤Ç¤Ï39.9¤ÈÃøÌÀ¤Ë¾å¾º¤¹¤ë¡¢¤È¤¤¤¦¤³¤È¤Ç¤¹¡£¤³¤ó¤Ê¤Ë¤¢¤ë¤È¤ÏÃΤé¤Ê¤«¤Ã¤¿¡£
¤½¤ì¤«¤éÍ¢·ì»þ¤Î¹â¥«¥ê¥¦¥à·ì¾É¤Î¥ê¥¹¥¯¤È¤Ê¤ëÍ×°ø¤¬µó¤²¤é¤ì¡¢¤½¤Î¥á¥«¥Ë¥º¥à¤¬Ãà°ìÀâÌÀ¤·¤Æ¤¢¤ê¡¢¤½¤ì¤âÌÌÇò¤«¤Ã¤¿¤Ç¤¹¡£¤½¤ÎÃæ¤Ë¤Ï¥¢¥·¥É¡¼¥·¥¹¡¢ÄãÂβ¹¡¢¹â·ìÅü¤Ê¤É¾å¤Ëµó¤²¤¿¤â¤Î¤Î¤Û¤«¡¢¦Â¥Ö¥í¥Ã¥«¡¼¤ÎÅêÍ¿¤ä¥Ý¥ó¥Ô¥ó¥°¤Ê¤É¤â¤¢¤ê¤Þ¤·¤¿¡£¤¤¤º¤ì¤âËã¿ìÃæ¤Ëµ¯¤³¤ê¤ä¤¹¤¤¤³¤È¤Ð¤«¤ê
¡£µ¤¤ò¤Ä¤±¤Þ¤¹¡£
Performance of residents and anesthesiologists in a simulation based skill assessment
Anesthesiology 2007;107:703-713
Ëã¿ì²Ê°å¤ÈËã¿ì¥ì¥¸¥Ç¥ó¥È¤ËÂФ·¡¢¥Þ¥Í¥¥ó¤Ë¤è¤ë¡Ö¼þ½Ñ´ü¥È¥é¥Ö¥ë¥·¥å¥ß¥ì¡¼¥·¥ç¥ó¡×¤òÂ賤·¤Æ¤â¤é¤¤¡¢¤¢¤é¤«¤¸¤á·è¤á¤é¤ì¤¿¥Á¥§¥Ã¥¯¥Ý¥¤¥ó¥È¤¬¤É¤ì¤À¤±¥¯¥ê¥¢¤Ç¤¤Æ¤¤¤ë¤«¤Çɾ²Á¤ò¹Ô¤¦¡¢¤È¤¤¤¦¼ñ»Ý¤Ç¤¹¡£
12¤Î¥·¥Ê¥ê¥ª¤òÍѰա£¤¤¤º¤ì¤â¼ê½ÑÃæ¤Ëµ¯¤³¤ê¤ä¤¹¤¤¡¢¤¢¤ë¤¤¤Ïµ¯¤¤¿¤È¤¤Ë¤Ï¿×®¤ËÂбþ¤·¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¤â¤Î¤Ð¤«¤ê¤Ç¤¹¡£
¶ñÂÎŪ¤Ë¤Ïµ¤´É»ÙáÛÚ»¡¢¥¢¥Ê¥Õ¥£¥é¥¥·¡¼¡¢¿´¼¼ºÙư¡¢¿´¶Úµõ·ì¡¢ÊÒÇÙÁÞ´É¡¢¶ÛÄ¥Àµ¤¶»¡¢°À¹âÇ®¾É¡¢µ¤´ÉÆâ¥Á¥å¡¼¥Ö¤ÎÊĺɡ¢Á´ÀÔËã¡¢»ÀÁǶ¡µë¥é¥¤¥ó¤ÎÅÓÀä¡¢¹â¥«¥ê¥¦¥à·ì¾É¡¢µÞÀ½Ð·ì¡£
Î㤨¤Ð¥¢¥Ê¥Õ¥£¥é¥¥·¡¼¤Ê¤é¡µÛÆþ»ÀÁÇÇ»ÅÙ¤ò¾å¤²¤ë¢Ä°¿Ç£·ì°µ¤Î¥Á¥§¥Ã¥¯¤¿ÇÃÇ¥¹³À¸ºÞ¤ÎÃæ»ß¦¥¨¥Ô¥Í¥Õ¥ê¥óÅêÍ¿
¤Î6¤Ä¤Î¥Á¥§¥Ã¥¯¥Ý¥¤¥ó¥È¤Î¤¦¤Á¡¢¤¤¤¯¤ÄÀµ²ò¤Ç¤¤¿¤«¤ò¥Ñ¡¼¥»¥ó¥È¤Ç¥¹¥³¥¢²½¤¹¤ë¤ï¤±¤Ç¤¹¡£
·ë²Ì¤Ï¡¢¤Þ¤¢Åö¤¿¤êÁ°¤À¤±¤É¥¸¥å¥Ë¥¢¥ì¥¸¥Ç¥ó¥È¤Î¥¹¥³¥¢¤¬¡¢¥·¥Ë¥¢¥ì¥¸¥Ç¥ó¥È¤äËã¿ì²Ê°å¤ËÈæ¤Ù¤ÆÄ㤫¤Ã¤¿¡¢¤È¤¤¤¦¤â¤Î¤Ç¤·¤¿¡£
¤Ç¤â¡¢¥·¥Ë¥¢¤ÈËã¿ì²Ê°å¤Î´Ö¤Ë¤½¤ó¤Ê¤Ë°ã¤¤¤Ï¤Ê¤«¤Ã¤¿¤ß¤¿¤¤¤Ç¡¢¥·¥ß¥å¥ì¡¼¥·¥ç¥ó¤ËÌäÂ꤬¤¢¤ë¤Î¤«¡ÊÌäÂ꤬´Êñ¤¹¤®¡¢Æñ¤·¤¹¤®¤È¤«¡Ë¡¢Ëã¿ì²Ê°å¤ÎǯÎð¤¬Ê¿¶Ñ45ºÐ¤°¤é¤¤¤Ç¥·¥ß¥å¥ì¡¼¥·¥ç¥ó¤È¤¤¤¦¤â¤Î¤ËÆëÀ÷¤ß¤¬¤Ê¤¤¤«¤éº¹¤¬½Ð¤Ê¤¤¤Î¤«Ž¥Ž¥Ž¥¤Ê¤É¤È¹Í»¡¤µ¤ì¤Æ¤Þ¤·¤¿¡£
ȯɽ¤Î»þ¤ËËã¿ì²Ê°å¤Î¤³¤È¤ò¡ÖǯÇÛ¤ÎËã¿ì²Ê°å¡×¤È¸À¤Ã¤Æ¤·¤Þ¤¤¡¢½÷ÀÉôŤÎÈ¿´¶¤òÇ㤤¤Þ¤·¤¿¡£¡Ö¥Ù¥Æ¥é¥ó¤Î¡×¤È¸À¤¤¤Ê¤ª¤·¡¢²¿¤È¤«µö¤·¤Æ¤â¤é¤¤¤Þ¤·¤¿¡¢¼ºÇÔ¡£
¸¦µæ¤½¤Î¤â¤Î¤è¤ê¤â¥·¥Ê¥ê¥ªÆâÍÆ¤È¡¢¥Á¥§¥Ã¥¯¥Ý¥¤¥ó¥È¤¬½ñ¤«¤ì¤¿°ìÍ÷ɽ¤¬ÂçÊÑ»²¹Í¤Ë¤Ê¤ë¤â¤Î¤À¤Ã¤¿¤Î¤ÇÆÉ¤ó¤Ç¤ß¤Þ¤·¤¿¡£Ëã¿ì²Ê°å¤Ç¤Ê¤¯¤Æ¤âÃΤäƤª¤¤¤ÆÂ»¤Ï¤Ê¤¤ÆâÍÆ¤Ç¤·¤¿¤è¡£
¤ª¤«¤²¤Ç¡Ö¤Ê¤«¤Ê¤«¤¿¤á¤Ë¤Ê¤ë¤«¤éɽ¤ÎÆâÍÆ¤òÁ´ÉôÀâÌÀ¤·¤Æ¡×¤Ê¤É¤ÈÉôŤ˸À¤ï¤ì¡¢¤³¤ì¤â¡ÖǯÇۡפȤ¤¤Ã¤¿»ÅÊÖ¤·¤À¤í¤¦¤«¤È»×¤¤¤Ä¤ÄÁ´Éô²òÀ⤷¤Þ¤·¤¿¡£
Controlled comparison between betamethasone gel and lidocaine jelly applied over tracheal tube to reduce postoperative sore throat,cough,and hourseness
Br J Anaesth 2008;100:215-18
Á޴ɤò¤¹¤ë¤È¤¤Ï¤¹¤Ù¤ê¤ò¤è¤¯¤¹¤ë¡¢°öƬÄˤò·Ú¸º¤¹¤ë¤Ê¤É¤ÎÍýͳ¤Ç¡¢¥Á¥å¡¼¥Ö¤Ë¥¥·¥í¥«¥¤¥ó¥¼¥ê¡¼¤ò¤Ä¤±¤Þ¤¹¡£º£¤Þ¤Ç¤¤¤í¤¤¤íɱ¡¤òÂØ¤ï¤ê¡¢É±¡¤Ë¤è¤Ã¤Æ¿§¡¹¤ä¤êÊý¤Ë°ã¤¤¤¬¤¢¤ë¤Ê¤¢¡¢¤È»×¤¦¤³¤È¤â¤·¤Ð¤·¤Ð¤Ç¤·¤¿¤±¤É¡¢¤³¤Î¥¥·¥í¥«¥¤¥ó¥¼¥ê¡¼¤Ï½ê¤¬ÊѤï¤Ã¤Æ¤âÊѤï¤é¤Ê¤¤¤â¤Î¤ÎÂåɽ¤À¤È»×¤¤¤Þ¤¹¡£
»ä¡¢¤³¤Î¥¥·¥í¥«¥¤¥ó¥¼¥ê¡¼¤Ë¤º¤Ã¤Èµ¿Ìä¤òÊú¤¤¤Æ¤ª¤ê¤Þ¤·¤Æ¡£ÄãÇ»Å٤ȤϤ¤¤¨¥¥·¥í¥«¥¤¥ó¤ò´Þ¤à¤Î¤Ê¤é¡¢¤³¤ì¤Ë¤è¤ë¤·¤Ó¤ì´¶¤È¤¤¤¦¤Î¤âÅöÁ³¤¢¤ë¤Î¤Ç¤Ï¤Ê¤¤¤«¡¢¥¥·¥í¥«¥¤¥ó¤¬Æþ¤Ã¤Æ¤¤¤Ê¤±¤ì¤ÐÀ¸¤¸¤Ê¤«¤Ã¤¿°öƬ¹¢Æ¬¤Î°ãÏ´¶¤È¤¤¤¦¤Î¤â¤¢¤ë¤Î¤Ç¤Ï¤Ê¤¤¤«¡¢¤È4ǯÌܤ°¤é¤¤¤Î¤È¤¤«¤éÀ¸°Õµ¤¤Ë¹Í¤¨¤Æ¤ª¤ê¤Þ¤·¤¿¡£
¤À¤«¤é°ì»þ´ü¥¥·¥í¥«¥¤¥ó¥¼¥ê¡¼¤Ê¤·¤Ç¡¢¿å¤ò¤Ä¤±¤ë¤À¤±¤ÇÁ޴ɤò¤·¤Æ¤¤¤¿¤³¤í¤â¤¢¤Ã¤¿¤Î¤Ç¤¹¡£¤Ç¤â°öƬÄˤϤ¢¤Þ¤ê¸º¤é¤Ê¤¤¤É¤³¤í¤«¡¢Áý¤¨¤¿¤è¤¦¤Ê°õ¾Ý¤¬¤¢¤Ã¤¿¤Î¤Ç¤¹¤°»ß¤á¤Þ¤·¤¿¡£¤ä¤Ã¤Ñ¤ê¿å¤À¤±¤¸¤ã¤¢¤À¤á¤À¡¢²¿¤«Âå¤ï¤ê¤Ë¤Ê¤ë¤â¤Î¤¬É¬ÍפÀ¤È»×¤Ã¤Æ¤¤¤¿¤ó¤Ç¤¹¡£
¤³¤ÎÏÀʸ¤Ï¥¤¥ó¥É¤ÎÏÀʸ¤Ç¡¢¥Ù¥¿¥á¥µ¥¾¥ó¡Ê¥ê¥ó¥Ç¥í¥ó¡Ë¤ò´Þ¤à¥¸¥§¥ë¤Þ¤¿¤Ï¥¥·¥í¥«¥¤¥ó¥¼¥ê¡¼¤òÅÉÉÛ¡¢¤¢¤ë¤¤¤Ï²¿¤âÉÕ¤±¤º¤Ëµ¤´ÉÁ޴ɤò¹Ô¤¤¡¢¤½¤ì¤¾¤ì¤Î½Ñ¸å¤Î°öƬÄË¡¢³±¡¢ÓÎÀ¼¤ÎȯÀ¸Î¨¤òÄ´¤Ù¤Æ¤ª¤ê¤Þ¤¹¡£
·ë²Ì¡¢¤½¤ì¤¾¤ì¤ÎȯÀ¸ÉÑÅ٤ϥ٥¿¥á¥µ¥¾¥ó¡¢¥ê¥É¥«¥¤¥ó¡¢¥³¥ó¥È¥í¡¼¥ë¤Î½ç¤Ë
°öƬÄËŽ¥Ž¥Ž¥40%,100%,100%
³±ÓÖŽ¥Ž¥Ž¥6%,40%,28%
ÓÎÀ¼Ž¥Ž¥Ž¥4.1%,32.9%,50% ¤¤¤º¤ì¤â24»þ´Ö¸å
¤Ç¡¢¤¤¤º¤ì¤â¥Ù¥¿¥á¥µ¥¾¥ó¤¬Í°Õ¤ËÄ㤫¤Ã¤¿¤È¤¤¤¦¤³¤È¤Ç¤¹¡£
¥Ù¥¿¥á¥µ¥¾¥ó¤¹¤´¤¤¡¢¤Ç¤â¤³¤ÎÀ½ºÞ¤ÏÆüËܤǤϼê¤ËÆþ¤é¤Ê¤¤¤ß¤¿¤¤¡£»Äǰ¡£
¤·¤«¤·¡¢¥ê¥É¥«¥¤¥ó¤È¥³¥ó¥È¥í¡¼¥ë¤Î´Ö¤Îº¹¤¬»×¤Ã¤¿¤è¤ê¾¯¤Ê¤¤¤Î¤Ë¶Ã¤¤Þ¤·¤¿¡£ÉÕ¤±¤Ê¤¤¤è¤ê¤Ï¤¤¤¤¡¢¤È¤¤¤Ã¤¿¤È¤³¤í¤Ç¤·¤ç¤¦¤«¡£


